{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:07:26Z","timestamp":1776942446679,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021A1515012228"],"award-info":[{"award-number":["2021A1515012228"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2020A1515110560"],"award-info":[{"award-number":["2020A1515110560"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021A1515410002"],"award-info":[{"award-number":["2021A1515410002"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bioorg.2024.107385","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T02:03:17Z","timestamp":1713405797000},"page":"107385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Synthesis and evaluation of pentacyclic triterpenoids conjugates as novel HBV entry inhibitors targeting NTCP receptor"],"prefix":"10.1016","volume":"147","author":[{"given":"Yixin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meitao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangwan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Mahal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanhong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107385_b0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.coviro.2018.04.006","article-title":"Perspectives and limitations for nucleo(t)side analogs in future HBV therapies","volume":"30","author":"Levrero","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.bioorg.2024.107385_b0010","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41575-019-0179-x","article-title":"Insights into the success and failure of systemic therapy for hepatocellular carcinoma","volume":"16","author":"Bruix","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bioorg.2024.107385_b0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11901-010-0041-7","article-title":"Pros and cons of peginterferon versus nucleos(t)ide analogues for treatment of chronic hepatitis B","volume":"9","author":"Sonneveld","year":"2010","journal-title":"Curr Hepat Rep"},{"key":"10.1016\/j.bioorg.2024.107385_b0020","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2174\/138955710791572442","article-title":"Recent advances in the chemistry of phthalimide analogues and their therapeutic potential","volume":"10","author":"Sharma","year":"2010","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bioorg.2024.107385_b0025","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.bioorg.2024.107385_b0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.antiviral.2015.06.002","article-title":"NTCP opens the door for hepatitis B virus infection","volume":"121","author":"Yan","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bioorg.2024.107385_b0035","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/jvh.13490","article-title":"Clinical effects of NTCP-inhibitor myrcludex B","volume":"28","author":"Cheng","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bioorg.2024.107385_b0040","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3851\/IMP2965","article-title":"The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide","volume":"20","author":"Ko","year":"2015","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bioorg.2024.107385_b0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.antiviral.2015.06.007","article-title":"Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity","volume":"120","author":"Wang","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bioorg.2024.107385_b0050","article-title":"Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP","volume":"7","author":"Donkers","year":"2017","journal-title":"Sci. Rep.-UK"},{"key":"10.1016\/j.bioorg.2024.107385_b0055","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jhep.2016.11.009","article-title":"Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity","volume":"66","author":"Shimura","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bioorg.2024.107385_b0060","article-title":"Curcumin inhibited hepatitis B viral entry through NTCP binding","volume":"11","author":"Thongsri","year":"2021","journal-title":"Sci. Rep.-UK"},{"key":"10.1016\/j.bioorg.2024.107385_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105184","article-title":"Ergosterol peroxide inhibits HBV infection by inhibiting the binding of the pre-S1 domain of LHBsAg to NTCP","volume":"195","author":"Huang","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bioorg.2024.107385_b0070","article-title":"Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids","volume":"10","author":"Kirstgen","year":"2020","journal-title":"Sci. Rep.-UK"},{"key":"10.1016\/j.bioorg.2024.107385_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/v14040764","article-title":"Fungal secondary metabolite exophillic acid selectively inhibits the entry of hepatitis B and D viruses","volume":"14","author":"Kobayashi","year":"2022","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.bioorg.2024.107385_b0080","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2014.09.009","article-title":"(-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes","volume":"111","author":"Huang","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bioorg.2024.107385_b0085","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2165\/00002018-200528110-00001","article-title":"Risk management strategies in the postmarketing period - safety experience with the US and European bosentan surveillance programmes","volume":"28","author":"Segal","year":"2005","journal-title":"Drug Saf."},{"key":"10.1016\/j.bioorg.2024.107385_b0090","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/FTD.0b013e31826a6306","article-title":"Old and new antirheumatic drugs and the risk of hepatotoxicity","volume":"34","author":"Anelli","year":"2012","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.bioorg.2024.107385_b0095","first-page":"381","article-title":"Long-term risk of rosiglitazone on cardiovascular events - a systematic review and meta-analysis","volume":"69","author":"Cheng","year":"2018","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.bioorg.2024.107385_b0100","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm034265a","article-title":"Synthesis and antiviral activity of helioxanthin analogues","volume":"48","author":"Yeo","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107385_b0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3851\/IMP1686","article-title":"Helioxanthin analogue 8\u20131 inhibits duck hepatitis B virus replication in cell culture","volume":"21","author":"Ying","year":"2010","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.bioorg.2024.107385_b0110","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/jm101325h","article-title":"Design and synthesis of oxymatrine analogues overcoming drug resistance in hepatitis B virus through targeting host heat stress cognate 70","volume":"54","author":"Gao","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107385_b0115","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ejmech.2012.05.012","article-title":"Design, synthesis, and molecular hybrids of caudatin and cinnamic acids as novel anti-hepatitis B virus agents","volume":"54","author":"Wang","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107385_b0120","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/med.21484","article-title":"Recent progress in the antiviral activity and mechanism study of pentacyclic triterpenoids and their derivatives","volume":"38","author":"Xiao","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2024.107385_b0125","first-page":"118","article-title":"Immunomodulatory effects and structure-activity relationship of botanical pentacyclic triterpenes: a review","volume":"12","author":"Harun","year":"2020","journal-title":"Chin Herb Med"},{"key":"10.1016\/j.bioorg.2024.107385_b0130","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.phymed.2015.05.001","article-title":"Anti-hepatitis B virus activities of friedelolactones from viola diffusa ging","volume":"22","author":"Dai","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2024.107385_b0135","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.bmcl.2018.03.076","article-title":"Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors","volume":"28","author":"Li","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107385_b0140","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1016\/j.bmc.2010.06.092","article-title":"Conjugates of betulin derivatives with AZT as potent anti-HIV agents","volume":"18","author":"Xiong","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bioorg.2024.107385_b0145","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1016\/j.bmcl.2014.09.079","article-title":"Synthesis and cytotoxic evaluation of novel ester-triazole-linked triterpenoid-AZT conjugates","volume":"24","author":"Dang","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107385_b0150","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bmcl.2018.12.040","article-title":"Design, synthesis and biological evaluation of novel HIV-1 protease inhibitors with pentacyclic triterpenoids as P2-ligands","volume":"29","author":"Zhu","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107385_b0155","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejmech.2016.01.005","article-title":"Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors","volume":"110","author":"Wang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107385_b0160","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1039\/C7MD00245A","article-title":"Synthesis of novel pentacyclic triterpene-Neu5Ac2en derivatives and investigation of their in vitro anti-influenza entry activity","volume":"8","author":"Shi","year":"2017","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2024.107385_b0165","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.ejmech.2017.10.070","article-title":"Multivalent oleanolic acid human serum albumin conjugate as nonglycosylated neomucin for influenza virus capture and entry inhibition","volume":"143","author":"Yang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107385_b0170","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ejmech.2018.12.006","article-title":"Synthesis, structure activity relationship and in vitro anti-influenza virus activity of novel polyphenol-pentacyclic triterpene conjugates","volume":"163","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107385_b0175","first-page":"130","article-title":"Taxoids: cancer-fighting compounds from nature","volume":"10","author":"Kingston","year":"2007","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1016\/j.bioorg.2024.107385_b0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000246787","article-title":"Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled, double-blind study","volume":"189","author":"Syed","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.bioorg.2024.107385_b0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/095632029800900307","article-title":"Inhibitory effects of podophyllotoxin derivatives on herpes simplex virus replication","volume":"9","author":"Sudo","year":"1998","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.bioorg.2024.107385_b0190","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.bmcl.2003.12.039","article-title":"Synthesis and cytotoxicity of hydrophobic esters of podophyllotoxins","volume":"14","author":"Lopez-Perez","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107385_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25010183","article-title":"Lignans and their derivatives from plants as antivirals","volume":"25","author":"Cui","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107385_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2023.100412","article-title":"Potential multifunctional components explored in Chinese herbal medicine against hepatitis B combining multi-target affinity ultrafiltration HPLC\/MS","volume":"3","author":"Feng","year":"2023","journal-title":"Phytomedicine plus"},{"key":"10.1016\/j.bioorg.2024.107385_b0205","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3891\/acta.chem.scand.47-1190","article-title":"New compounds related to podophyllotoxin and congeners: synthesis, structure elucidation and biological testing","volume":"47","author":"Hansen","year":"1993","journal-title":"Acta Chem Scand (Cph)"},{"key":"10.1016\/j.bioorg.2024.107385_b0210","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2013.12.052","article-title":"Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP","volume":"443","author":"Iwamoto","year":"2014","journal-title":"Biochem. Bioph. Res. Co."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824002906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824002906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T09:01:14Z","timestamp":1715677274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824002906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":42,"alternative-id":["S0045206824002906"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107385","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of pentacyclic triterpenoids conjugates as novel HBV entry inhibitors targeting NTCP receptor","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107385"}}